Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.
Identifieur interne : 000433 ( PubMed/Checkpoint ); précédent : 000432; suivant : 000434Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.
Auteurs : Andrew Gratzon [États-Unis] ; Jerette Schultz [États-Unis] ; Kristine Secrest [États-Unis] ; Kenneth Lee [États-Unis] ; Jeffrey Feiner [États-Unis] ; Richard D. Klein [États-Unis]Source :
- Annals of surgical oncology [ 1534-4681 ] ; 2017.
Abstract
BACKGROUND: Secondary lymphedema following breast cancer therapy remains a major problem. Vascularized lymph node transfer (VLNT) is a surgical treatment for lymphedema that has shown promising results, but limited studies in the United States have investigated outcomes for single-stage VLNT to the axilla. The goal of this prospective, ongoing study was to investigate the clinical, psychosocial, and functional outcomes of patients who underwent VLNT for the treatment of upper extremity lymphedema after breast cancer therapy.
DOI: 10.1245/s10434-016-5614-4
PubMed: 27734176
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27734176Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.</title><author><name sortKey="Gratzon, Andrew" sort="Gratzon, Andrew" uniqKey="Gratzon A" first="Andrew" last="Gratzon">Andrew Gratzon</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Schultz, Jerette" sort="Schultz, Jerette" uniqKey="Schultz J" first="Jerette" last="Schultz">Jerette Schultz</name><affiliation wicri:level="2"><nlm:affiliation>University of Central Florida College of Medicine, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Central Florida College of Medicine, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Secrest, Kristine" sort="Secrest, Kristine" uniqKey="Secrest K" first="Kristine" last="Secrest">Kristine Secrest</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Lee, Kenneth" sort="Lee, Kenneth" uniqKey="Lee K" first="Kenneth" last="Lee">Kenneth Lee</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Feiner, Jeffrey" sort="Feiner, Jeffrey" uniqKey="Feiner J" first="Jeffrey" last="Feiner">Jeffrey Feiner</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Klein, Richard D" sort="Klein, Richard D" uniqKey="Klein R" first="Richard D" last="Klein">Richard D. Klein</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA. richard.klein@orlandohealth.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27734176</idno><idno type="pmid">27734176</idno><idno type="doi">10.1245/s10434-016-5614-4</idno><idno type="wicri:Area/PubMed/Corpus">000581</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000581</idno><idno type="wicri:Area/PubMed/Curation">000581</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000581</idno><idno type="wicri:Area/PubMed/Checkpoint">000581</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000581</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.</title><author><name sortKey="Gratzon, Andrew" sort="Gratzon, Andrew" uniqKey="Gratzon A" first="Andrew" last="Gratzon">Andrew Gratzon</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Schultz, Jerette" sort="Schultz, Jerette" uniqKey="Schultz J" first="Jerette" last="Schultz">Jerette Schultz</name><affiliation wicri:level="2"><nlm:affiliation>University of Central Florida College of Medicine, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Central Florida College of Medicine, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Secrest, Kristine" sort="Secrest, Kristine" uniqKey="Secrest K" first="Kristine" last="Secrest">Kristine Secrest</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Lee, Kenneth" sort="Lee, Kenneth" uniqKey="Lee K" first="Kenneth" last="Lee">Kenneth Lee</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Feiner, Jeffrey" sort="Feiner, Jeffrey" uniqKey="Feiner J" first="Jeffrey" last="Feiner">Jeffrey Feiner</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Klein, Richard D" sort="Klein, Richard D" uniqKey="Klein R" first="Richard D" last="Klein">Richard D. Klein</name><affiliation wicri:level="2"><nlm:affiliation>Orlando Health, Orlando, FL, USA. richard.klein@orlandohealth.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Orlando Health, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author></analytic><series><title level="j">Annals of surgical oncology</title><idno type="eISSN">1534-4681</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">BACKGROUND: Secondary lymphedema following breast cancer therapy remains a major problem. Vascularized lymph node transfer (VLNT) is a surgical treatment for lymphedema that has shown promising results, but limited studies in the United States have investigated outcomes for single-stage VLNT to the axilla. The goal of this prospective, ongoing study was to investigate the clinical, psychosocial, and functional outcomes of patients who underwent VLNT for the treatment of upper extremity lymphedema after breast cancer therapy.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27734176</PMID><DateCreated><Year>2016</Year><Month>10</Month><Day>13</Day></DateCreated><DateRevised><Year>2017</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-4681</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of surgical oncology</Title><ISOAbbreviation>Ann. Surg. Oncol.</ISOAbbreviation></Journal><ArticleTitle>Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.</ArticleTitle><Pagination><MedlinePgn>1475-1481</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1245/s10434-016-5614-4</ELocationID><Abstract><AbstractText Label="ABSTARCT" NlmCategory="UNASSIGNED">BACKGROUND: Secondary lymphedema following breast cancer therapy remains a major problem. Vascularized lymph node transfer (VLNT) is a surgical treatment for lymphedema that has shown promising results, but limited studies in the United States have investigated outcomes for single-stage VLNT to the axilla. The goal of this prospective, ongoing study was to investigate the clinical, psychosocial, and functional outcomes of patients who underwent VLNT for the treatment of upper extremity lymphedema after breast cancer therapy.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">VLNT to the axilla were performed on patients with upper extremity lymphedema after breast cancer therapy. Patients were evaluated preoperatively and postoperatively at 1-, 3-, 6-, 9-, and 12-month intervals by circumferential measurements, pain/heaviness scales, and the LYMQOL questionnaire.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty patients met the study criteria. Preliminary results showed a decrease in arm volumes by 34.57 % at 1 month, 52.03 % at 3 months, 42.34 % at 6 months, 65.23 % at 9 months, and 58.68 % at 12 months. Pain and heaviness consistently decreased over time to 0.38 and 1.67 respectively at 12 months. Overall quality of life scores steadily improved from 5.72 preoperatively to 7.79 at 12 months. There was a significant decrease in the number of infections of the affected arm postoperatively and a decreased need for physiotherapy. Complications occurred in 17 patients and consisted mainly of minor wound complications.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VLNT continues to demonstrate its value as a safe and effective treatment option for lymphedema after breast cancer therapy. Significant reductions in volume are accompanied by a decrease in symptoms and improvement in quality of life.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gratzon</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Orlando Health, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Jerette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Secrest</LastName><ForeName>Kristine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Orlando Health, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Orlando Health, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feiner</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Orlando Health, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Orlando Health, Orlando, FL, USA. richard.klein@orlandohealth.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Reconstructive Surgery, UF Health Cancer Center at Orlando Health, Orlando, FL, 32806, USA. richard.klein@orlandohealth.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg Oncol</MedlineTA><NlmUniqueID>9420840</NlmUniqueID><ISSNLinking>1068-9265</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27734176</ArticleId><ArticleId IdType="doi">10.1245/s10434-016-5614-4</ArticleId><ArticleId IdType="pii">10.1245/s10434-016-5614-4</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Floride</li></region></list><tree><country name="États-Unis"><region name="Floride"><name sortKey="Gratzon, Andrew" sort="Gratzon, Andrew" uniqKey="Gratzon A" first="Andrew" last="Gratzon">Andrew Gratzon</name></region><name sortKey="Feiner, Jeffrey" sort="Feiner, Jeffrey" uniqKey="Feiner J" first="Jeffrey" last="Feiner">Jeffrey Feiner</name><name sortKey="Klein, Richard D" sort="Klein, Richard D" uniqKey="Klein R" first="Richard D" last="Klein">Richard D. Klein</name><name sortKey="Lee, Kenneth" sort="Lee, Kenneth" uniqKey="Lee K" first="Kenneth" last="Lee">Kenneth Lee</name><name sortKey="Schultz, Jerette" sort="Schultz, Jerette" uniqKey="Schultz J" first="Jerette" last="Schultz">Jerette Schultz</name><name sortKey="Secrest, Kristine" sort="Secrest, Kristine" uniqKey="Secrest K" first="Kristine" last="Secrest">Kristine Secrest</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000433 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000433 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:27734176
|texte= Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27734176" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |